Advertisement

Topics

Edison Issues Update on GW Pharmaceuticals (GWPH)

10:20 EDT 22 Aug 2017 | FinanzNachrichten

LONDON, ENGLAND / ACCESSWIRE / August 22, 2017 / GW Pharmaceuticals (NASDAQ: GWPH) recently announced that a rolling NDA filing for Epidiolex in both Dravet syndrome and Lennox-Gastaut syndrome (LG...

Original Article: Edison Issues Update on GW Pharmaceuticals (GWPH)

NEXT ARTICLE

More From BioPortfolio on "Edison Issues Update on GW Pharmaceuticals (GWPH)"

Advertisement
Quick Search
Advertisement
Advertisement